COVID-19: A Global health concern

COVID-19 IgM/IgG Rapid Qualitative Screening Test

Fast detection of COVID-19

The test can be performed in 10 minutes from patients' whole blood, serum or plasma.

Suitable for testing a large number of patients

Due to its simplicity and minimal sample preparation time, this kit can be used for screening a larger number of people.

Affordable testing expenses

Since highly trained personnel or expensive equipment is not needed, the cost of testing is relatively low.

Certified Quality Standards

Manufactured under ISO13485:2016 and received provisional authorisation from Health Sciences Authority (Singapore)

ProTect™ COVID-19 RT-qPCR Kit


The kit provides all the necessary reagents for the in vitro qualitative detection of the COVID-19 virus from respiratory specimens and serum samples.

Tested and reliable protocol

The kit is compatible with the US CDC protocol and received provisional authorisation from Health Sciences Authority (Singapore).

Early detection

The amplification of viral nucleic acids provides detection at very early stages of the infection, even before symptomps occur.

Wide range of suitable samples

Viral particles are present in throat, sputum and nasopharingeal swabs, making it easy to acquire specimens.

Why testing is important?

We want to know the total number of people infected with COVID-19. To know this, it is necessary to have widespread testing.

When testing is too low we do not have a clear picture of what’s going on.

Testing is crucial as it allows the infected person to avoid infecting others and to quickly receive the care they need. And it is crucial for all of us to understand the prevalence of the disease, to understand how the disease evolves, and to allow us to take evidence-based decisions for counter measures that slow down the spread of the disease.


Frequently asked questions

There are several approaches that can be used to identify an infection, these focus on detecting either viral proteins (Early detection), viral nucleotide sequences (Early detection) or antibodies (Later detection) raised against specific viral components.

  1. Quantitative Polymerase Chain Reaction (qPCR) Nucleotide detection, every viral particle contains a specific nucleotide sequence that is embedded into its target cells and is crucial for the virus to hijack cellular mechanisms to drive the production of new viral particles. These nucleotide sequences can be isolated and amplified using PCR, and further quantified using fluorescent probes using qPCR systems.

  2. Enzyme-linked immunosorbent assays (ELISAs) are more rapid serology tests that provide a readout of antigen-antibody interactions. Essentially, patient antibodies are “sandwiched” between the viral protein of interest and reporter antibodies, so that any active patient antibodies are detected. Lateral flow Assays (LFA’s) are also based on these principles but are packaged into a easy to use format.

  3. Immunofluorescent assay (IFA) shows whether a patient has antibodies to a pathogen by displaying a fluorescent signal when patient antibodies interact with virus proteins.

  4. Neutralization tests can indicate whether the patient has active, functional antibodies to the pathogen in question by measuring how much the patient antibodies can inhibit viral growth in the lab.

  5. Western blot tests, which can be used in laboratory settings to detect the presence of a protein of interest by the emission of a colored or fluorescent reporter when an active antibody interacts with the viral protein.
The WHO has recommended countries implement more widespread testing. You should check with your local healthcare provider if COVID-19 testing is available in your area. Although an increase in testing volumes may result in delays or lack of availability for milder cases.

The incubation period for the infection can vary from 2 to 14 days. This variation makes it difficult to pinpoint a timeframe when a person was infected and could vary by the same amount as the incubation period.

Patient antibodies (IgM/IgG) against the virus particles, which is tested by the COVID-19 IgM/IgG Rapid test kit, only appear after symptoms arise. The earliest time frame is 5 days after the onset of symptoms, when IgMs and IgGs can be visually detected using the LFA kit.

The ProTect™ COVID-19 RT-qPCR kit is based on the direct molecular diagnostics of the virus RNA. Based on other respiratory viral infections it is estimated that the detectable viral load is present after 3-4 days of infection.

Please refer to the individual brochures for accuracy information.
Please get in touch with us through the Contact form indicating the type and volume of the testing kits needed.

Technical information

  • All Camtech™ tests kits are manufactured under ISO 13485.

  • Our test kits have obtained provisional authorisation from the Singapore Health Sciences Authority (HSA).

  • Please note that our products are not to be used by consumers or marketed over the counter or directly to consumers and are only for use by certified healthcare establishments or where administered by a trained healthcare professional and in accordance to the "Instructions for Use" of the product.

  • The tests has not been reviewed by the FDA.

  • Negative results of the Rapid Test do not rule out SARS-CoV-2 infection, particularly in those who have been in contact with the virus.
    Follow-up testing with a molecular diagnostic method should be considered to rule out infection in these individuals.

  • Results from antibody testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection or to inform infection status.

  • Positive results may be due to past or present infection with non-SARS-CoV-2 coronavirus strains, such as coronavirus HKU1, NL63, OC43, or 229E.

  • Not for the screening of donated blood.

Contact Us

  • If you are a healthcare establishment or professional and would like to order a box of sample kits for evaluation, you may order on this website. Sample kits for evaluation are sold as a box of 20. You will need to provide the details of your healthcare establishment or practitioner details in order to purchase.

  • For larger orders, we have a Minimum Order Quantity. For such enquiries, please contact us on the form below.

  • If you are a hospital/ clinical research institute and would like to undertake a research collaboration on infected patient serum and blood samples kindly reach us below with your project description.

Camtech™ . Privacy Policy